Vitamin D3 Injection
- Packing: 1 Ml Ampoule.
- Available Strength : 300000 Iu/Ml, 600000 Iu/Ml
Description
Product Description: Vitamin D3 Injection is a meticulously formulated pharmaceutical solution containing cholecalciferol, the biologically active form of vitamin D3. This injection is designed to address vitamin D deficiency and related conditions. Manufactured to the highest quality standards, Vitamin D3 Injection offers essential support for maintaining calcium balance, bone health, and overall well-being.
Indications and Usage: Vitamin D3 Injection is indicated for the treatment and prevention of vitamin D deficiency, including cases where oral supplementation is not feasible or desirable. It is used to replenish depleted vitamin D levels and prevent or alleviate symptoms associated with deficiency states, such as osteomalacia, rickets, and hypocalcemia.
Dosage and Administration: The dosage of Vitamin D3 Injection varies depending on the severity of vitamin D deficiency and the patient's response to therapy. It is typically administered via intramuscular or subcutaneous injection under the supervision of a healthcare professional. The recommended dosage regimen may include loading doses followed by maintenance doses, tailored to the individual patient's needs.
Dosage Forms and Strengths: Vitamin D3 Injection is available as a sterile solution in vials containing specific concentrations of cholecalciferol formulated for parenteral administration. Each vial is carefully manufactured to ensure accurate dosing and optimal therapeutic outcomes.
Contraindications: This product is contraindicated in patients with a known hypersensitivity to cholecalciferol or any of the excipients. It should not be used in patients with hypercalcemia, vitamin D toxicity, or primary hyperparathyroidism. Additionally, it is contraindicated in patients with malabsorption syndromes or granulomatous diseases, as these conditions may predispose to vitamin D toxicity.
Warnings and Precautions: Healthcare providers should exercise caution when administering Vitamin D3 Injection to patients with renal impairment or hyperparathyroidism, as high doses of vitamin D may exacerbate these conditions. Patients should be monitored regularly for signs of hypercalcemia, including fatigue, weakness, nausea, and constipation. Long-term use of vitamin D supplements may increase the risk of renal calculi and cardiovascular events.
Adverse Reactions/Side Effects: Common adverse reactions associated with Vitamin D3 Injection include hypercalcemia, hypercalciuria, and hyperphosphatemia. Gastrointestinal symptoms, such as nausea, vomiting, and diarrhea, may also occur. Rarely, hypersensitivity reactions, including rash, itching, and anaphylaxis, may occur. Patients should be advised to report any unusual symptoms promptly.
Drug Interactions: Vitamin D3 may interact with certain medications, including corticosteroids, anticonvulsants, and diuretics. Healthcare providers should review the patient's medication profile carefully to identify potential drug interactions and adjust dosage as necessary to minimize risks.
Use In Specific Populations Description: Safety and efficacy of Vitamin D3 Injection in pediatric patients, pregnant women, and nursing mothers have not been established conclusively. Healthcare providers should assess the potential risks and benefits before prescribing this medication in these populations.
How Supplied/Storage and Handling: Vitamin D3 Injection is supplied as a sterile solution in vials for intramuscular or subcutaneous injection. It should be stored at controlled room temperature (20°C to 25°C) away from light and moisture. Care should be taken to ensure proper storage and handling to maintain the integrity of the product. Unused portions should be discarded according to standard procedures for biohazardous waste.
